ÂÜÀòÂÒÂ×

Inez de Greef-van der Sandt is a co-founder and managing partner at 3D-PharmXchange, a consultancy firm specializing in drug development solutions for Biotech and Pharma companies, and serves as CEO of Treeway, a biotech firm focused on therapies for neurodegenerative diseases, including ALS and Alzheimer's. In addition to these roles, Inez holds a fellowship at the Netherlands Academy of Engineering, is a founding board member at Onicor, and serves on the advisory board for Topsector Life Science Health and the industry advisory board for HEALTH-RI, promoting health data reuse for research and innovation. Inez has also contributed to various committees, including the Expert Committee for Stimulus Programmamanagement and the Steering Committee for PharmInvestHolland. Inez’s educational background includes a PhD in Pharmacology from Leiden University and an MSc in Medical Biology from the University of Amsterdam.